Filing Flows › Companies › Axsome Therapeutics › Timeline
Axsome Therapeutics stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions−5.1% to $132.37
Axsome Therapeutics (AXSM) stock fell 5% over the last 252 sessions, to $132.37. On the way it reported 4 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside) and 4 Form 144 notices of planned sales, and the company filed 1 material 8-K. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 2, 2026 | Earnings | Earnings: beat the EPS estimate by 60.9% | −6.0% (−5.5% vs SPY) | −8.7% (−6.0% vs SPY) | — |
| Sep 3, 2026 | Form 144 | Form 144: Mark Jacobson plans to sell $2.1M | −0.7% (−1.8% vs SPY) | +0.6% (+1.5% vs SPY) | −15.8% (−16.6% vs SPY) |
| Aug 10, 2026 | Earnings | Earnings: missed the EPS estimate by -26.9% | +3.8% (+3.8% vs SPY) | +0.4% (0.0% vs SPY) | −2.3% (−1.4% vs SPY) |
| Aug 6, 2026 | Form 144 | Form 144: Herriot Tabuteau plans to sell $979K | −1.3% (−1.1% vs SPY) | +0.8% (+0.5% vs SPY) | −2.1% (−2.6% vs SPY) |
| Aug 5, 2026 | Form 144 | Form 144: Herriot Tabuteau plans to sell $9.6M | +0.3% (+0.5% vs SPY) | +1.7% (+1.8% vs SPY) | −1.1% (−0.3% vs SPY) |
| Jul 1, 2026 | Form 144 | Form 144: Herriot Tabuteau plans to sell $12.0M | −1.7% (−1.6% vs SPY) | +0.3% (+0.5% vs SPY) | −4.2% (−3.5% vs SPY) |
| Jun 9, 2026 | 8-K | Directors and officers: departures, appointments, pay | +0.3% (+1.9% vs SPY) | +2.5% (+0.7% vs SPY) | −4.9% (−7.6% vs SPY) |
| May 4, 2026 | Earnings | Earnings: missed the EPS estimate by -46.0% | +8.0% (+8.4% vs SPY) | +5.1% (+2.8% vs SPY) | +7.3% (+2.1% vs SPY) |
| Feb 23, 2026 | Earnings | Earnings: beat the EPS estimate by 23.6% | −5.0% (−4.0% vs SPY) | −11.4% (−10.9% vs SPY) | −15.8% (−11.0% vs SPY) |
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Axsome Therapeutics: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.